{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:03:33Z","timestamp":1762866213423,"version":"3.44.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ygyno.2013.07.084","type":"journal-article","created":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T22:19:25Z","timestamp":1374185965000},"page":"231-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Adjuvant treatment for endometrial cancer: Literature review and recommendations by the Comit\u00e9 de l'\u00e9volution des pratiques en oncologie (CEPO)"],"prefix":"10.1016","volume":"131","author":[{"given":"M\u00e9lanie","family":"Morneau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Lalancette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thu","family":"Van Nguyen-Huynh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Claude","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Samou\u00eblian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Letarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Almanric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gino","family":"Boily","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Boulanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghislain","family":"Cournoyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e9lix","family":"Couture","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Normand","family":"Gervais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Goulet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Pascale","family":"Guay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Lemieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Lesp\u00e9rance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Letarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Morneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Ouellet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Pineau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghu","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u00eet","family":"Samson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Sid\u00e9ris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2012","series-title":"Statistiques canadiennes sur le cancer 2011","author":"Comit\u00e9 directeur de la Soci\u00e9t\u00e9 canadienne du cancer","key":"10.1016\/j.ygyno.2013.07.084_bb0005"},{"author":"National Cancer Institute","key":"10.1016\/j.ygyno.2013.07.084_bb0010"},{"key":"10.1016\/j.ygyno.2013.07.084_bb0015","series-title":"FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","first-page":"S105","article-title":"Carcinoma of the corpus uteri","volume":"95 Suppl. 1.","author":"Creasman","year":"2006"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.084_bb0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejogrb.2008.12.014","article-title":"Evaluation of prognostic factors and treatment outcomes in uterine carcinosarcoma","volume":"143","author":"Galaal","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"23","key":"10.1016\/j.ygyno.2013.07.084_bb0025","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"9658","key":"10.1016\/j.ygyno.2013.07.084_bb0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2013.07.084_bb0035","first-page":"CD007585","article-title":"Lymphadenectomy for the management of endometrial cancer","volume":"1","author":"May","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ygyno.2013.07.084_bb0040","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ijrobp.2011.04.014","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma \u2014 a prospective randomized study","volume":"82","author":"Sorbe","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9658","key":"10.1016\/j.ygyno.2013.07.084_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"Blake","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ygyno.2013.07.084_bb0050","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"9213","key":"10.1016\/j.ygyno.2013.07.084_bb0055","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ygyno.2013.07.084_bb0060","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0360-3016(01)01765-5","article-title":"The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial","volume":"51","author":"Creutzberg","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.084_bb0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-8258(03)00126-4","article-title":"Survival after relapse in patients with endometrial cancer: results from a randomized trial","volume":"89","author":"Creutzberg","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ygyno.2013.07.084_bb0070","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.2004.08.159","article-title":"Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial","volume":"22","author":"Creutzberg","year":"2004","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.07.084_bb0075","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ijrobp.2005.03.007","article-title":"Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review","volume":"63","author":"Scholten","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"13","key":"10.1016\/j.ygyno.2013.07.084_bb0080","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.2010.32.4590","article-title":"Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial","volume":"29","author":"Nout","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ygyno.2013.07.084_bb0085","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/IGC.0b013e3181a6c9df","article-title":"Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study","volume":"19","author":"Sorbe","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"9717","key":"10.1016\/j.ygyno.2013.07.084_bb0090","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.ygyno.2013.07.084_bb0095","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","article-title":"Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial","volume":"27","author":"Nout","year":"2009","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ygyno.2013.07.084_bb0100","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.ejca.2011.11.014","article-title":"Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data","volume":"48","author":"Nout","year":"2012","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2013.07.084_bb0105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2007.09.029","article-title":"Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study","volume":"108","author":"Susumu","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.07.084_bb0110","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.bjc.6603279","article-title":"Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial","volume":"95","author":"Maggi","year":"2006","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2013.07.084_bb0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study","volume":"24","author":"Randall","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.07.084_bb0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11136-006-9003-5","article-title":"Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study","volume":"16","author":"Bruner","year":"2007","journal-title":"Qual Life Res"},{"issue":"13","key":"10.1016\/j.ygyno.2013.07.084_bb0125","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","article-title":"Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer\u2013results from two randomised studies","volume":"46","author":"Hogberg","year":"2010","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.084_bb0130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2008.03.020","article-title":"Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy","volume":"110","author":"Kuoppala","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.084_bb0135","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0090-8258(90)90166-I","article-title":"Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study","volume":"36","author":"Morrow","year":"1990","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.084_bb0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000010297","article-title":"Adjuvant chemotherapy including cisplatin in endometrial carcinoma","volume":"50","author":"Fujimura","year":"2000","journal-title":"Gynecol Obstet Invest"},{"issue":"3","key":"10.1016\/j.ygyno.2013.07.084_bb0145","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ygyno.2008.11.014","article-title":"A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: a Gynecologic Oncology Group study","volume":"112","author":"Homesley","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.07.084_bb0150","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ygyno.2010.08.022","article-title":"Patient-reported peripheral neuropathy of doxorubicin and cisplatin with and without paclitaxel in the treatment of advanced endometrial cancer: results from GOG 184","volume":"119","author":"Cella","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"17","key":"10.1016\/j.ygyno.2013.07.084_bb0155","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/S0959-8049(02)00378-7","article-title":"Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer \u2014 a multicentre, open, controlled, prospectively randomised trial","volume":"38","author":"von Minckwitz","year":"2002","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2013.07.084_bb0160","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1525-1438.1998.09865.x","article-title":"Adjuvant medroxyprogesterone acetate in high-risk endometrial cancer","volume":"8","author":"COSA-NZ-UK Endometrial Cancer Groups","year":"1998","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2013.07.084_bb0165","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0959-8049(05)80303-X","article-title":"Treatment of FIGO (1971) stage I endometrial carcinoma with intensive surgery, radiotherapy and hormonotherapy according to pathological prognostic groups. Long-term results of a randomised multicentre study","volume":"29A","author":"De Palo","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2013.07.084_bb0170","series-title":"Results of one-institutional prospective clinical trial","first-page":"98","article-title":"Adjuvant progestagen therapy improves survival in patients with endometrial cancer after hysterectomy","volume":"14 Suppl.","author":"Urbanski","year":"1993"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.084_bb0175","first-page":"150","article-title":"Favourable influence of adjuvant hormone therapy by oxyprogesterone caproate (OPC) and by its combination with tamoxifen on 5-year survival rate of surgical and combined treatment of primary endometrial carcinoma patients","volume":"14","author":"Vishnevsky","year":"1993","journal-title":"Eur J Gynaecol Oncol"},{"issue":"6","key":"10.1016\/j.ygyno.2013.07.084_bb0180","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ejca.2008.01.019","article-title":"Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)","volume":"44","author":"Reed","year":"2008","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.084_bb0185","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ygyno.2007.07.070","article-title":"A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin\u2013ifosfamide and mesna (CIM) as post-surgical therapy in stage I\u2013IV carcinosarcoma (CS) of the uterus","volume":"107","author":"Wolfson","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.ygyno.2013.07.084_bb0190","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1471-0528.2007.01332.x","article-title":"Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis","volume":"114","author":"Johnson","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.ygyno.2013.07.084_bb0195","first-page":"CD003916","article-title":"Adjuvant radiotherapy for stage I endometrial cancer","volume":"3","author":"Kong","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ygyno.2013.07.084_bb0200","first-page":"CD003916","article-title":"Adjuvant radiotherapy for stage I endometrial cancer","volume":"2","author":"Kong","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ygyno.2013.07.084_bb0205","first-page":"CD003175","article-title":"Adjuvant chemotherapy for endometrial cancer after hysterectomy","volume":"10","author":"Johnson","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ygyno.2013.07.084_bb0210","first-page":"CD001040","article-title":"Adjuvant progestagens for endometrial cancer","volume":"6","author":"Martin-Hirsch","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.084_bb0215","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0301-2115(95)02359-3","article-title":"Adjuvant progestagen therapy for the treatment of endometrial cancer: review and meta-analyses of published randomised controlled trials","volume":"65","author":"Martin-Hirsch","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ygyno.2013.07.084_bb0220","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2012.30.15_suppl.5008","article-title":"Survival after radiation therapy for early-stage endometrial carcinoma: the Oslo study revisited after up to 43years of follow-up","volume":"30","author":"Lindemann","year":"2012","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.07.084_bb0225","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ygyno.2012.03.034","article-title":"Late-breaking Abstract 1: randomized phase III noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study","volume":"125","author":"Miller","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.07.084_bb0230","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3747\/co.v15i3.204","article-title":"Adjuvant hormonal therapy for stage I endometrial cancer","volume":"15","author":"Gien","year":"2008","journal-title":"Curr Oncol"},{"issue":"Suppl. 6","key":"10.1016\/j.ygyno.2013.07.084_bb0235","doi-asserted-by":"crossref","first-page":"vi35","DOI":"10.1093\/annonc\/mdr374","article-title":"Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"22","author":"Colombo","year":"2011","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.ygyno.2013.07.084_bb0240","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/0360-3016(95)00097-I","article-title":"Postoperative vaginal cuff irradiation using high dose rate remote afterloading: a phase II clinical protocol","volume":"32","author":"Noyes","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ygyno.2013.07.084_bb0245","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijrobp.2004.12.079","article-title":"Intravaginal high-dose-rate brachytherapy for stage I endometrial cancer: a randomized study of two dose-per-fraction levels","volume":"62","author":"Sorbe","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.ygyno.2013.07.084_bb0250","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/annonc\/mdm066","article-title":"Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysis","volume":"18","author":"Kong","year":"2007","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2013.07.084_bb0255","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.084_bb0260","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/gyno.1999.5569","article-title":"FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy","volume":"75","author":"Nelson","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ygyno.2013.07.084_bb0265","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ijrobp.2007.02.003","article-title":"Analysis of prognostic factors and patterns of recurrence in patients with pathologic stage III endometrial cancer","volume":"68","author":"Patel","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ygyno.2013.07.084_bb0270","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/gyno.1996.0274","article-title":"The effect of postsurgical therapy on stage III endometrial carcinoma","volume":"63","author":"Schorge","year":"1996","journal-title":"Gynecol Oncol"},{"issue":"20","key":"10.1016\/j.ygyno.2013.07.084_bb0275","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1200\/JCO.2001.19.20.4048","article-title":"Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study","volume":"19","author":"Hoskins","year":"2001","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.07.084_bb0280","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/annonc\/mdq401","article-title":"Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041)","volume":"22","author":"Nomura","year":"2011","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2013.07.084_bb0285","first-page":"803","article-title":"Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel-long-term follow-up","volume":"18","author":"Sorbe","year":"2008","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2013.07.084_bb0290","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/IGC.0b013e3181ad3dcb","article-title":"Leuven dose-dense paclitaxel\/carboplatin regimen in patients with primary advanced or recurrent endometrial carcinoma","volume":"19","author":"Vandenput","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2013.07.084_bb0295","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1447-0756.2010.01223.x","article-title":"Comparison of the efficacy between paclitaxel\/carboplatin and doxorubicin\/cisplatin for concurrent chemoradiation in intermediate- or high-risk endometrioid endometrial cancer: a single institution experience","volume":"36","author":"Kim","year":"2010","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.ygyno.2013.07.084_bb0300","first-page":"CD006812","article-title":"Adjuvant radiotherapy and\/or chemotherapy after surgery for uterine carcinosarcoma","volume":"1","author":"Galaal","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"4 Suppl.","key":"10.1016\/j.ygyno.2013.07.084_bb0305","first-page":"305S","article-title":"Rules of evidence and clinical recommendations on the use of antithrombotic agents","volume":"102","author":"Cook","year":"1992","journal-title":"Chest"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813009992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813009992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:34:16Z","timestamp":1758771256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813009992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0090825813009992"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.07.084","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant treatment for endometrial cancer: Literature review and recommendations by the Comit\u00e9 de l'\u00e9volution des pratiques en oncologie (CEPO)","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.07.084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}